TL;DR
This study investigated how an inflatable endorectal coil (ERC) affects prostate volume and shape during MRI. While the ERC significantly deforms the prostate's shape, it surprisingly doesn't alter the overall measured volume, suggesting that ERC-enhanced MRI data is reliable for clinical applications like PSA density calculations and radiation therapy planning.
What Problem Does This Paper Address?
Accurate measurement of prostate volume is crucial for various clinical applications, including prostate cancer screening, predicting benign prostatic hyperplasia (BPH) outcomes, and planning radiation therapy. Prostate-specific antigen (PSA) density, which normalizes PSA levels by prostate volume, is a key biomarker for distinguishing prostate cancer from BPH and assessing the risk of biochemical recurrence. Traditional methods for prostate volume estimation, like those using transrectal ultrasonography (TRUS), can suffer from inter-observer variability, especially with irregular prostates.
Magnetic Resonance Imaging (MRI) offers a more precise way to measure prostate volume. The use of an endorectal coil (ERC) in MRI is known to improve signal-to-noise ratio (SNR), leading to better image quality and localization of the prostate. However, there were prior reports suggesting that ERCs might actually decrease prostate volume measurements, which would have significant implications for clinical workflows relying on these measurements. This paper aims to clarify whether the use of an inflatable and flexible ERC alters the measured whole prostate volume and shape, and consequently, its impact on PSA density calculations.
Methods
The researchers conducted a prospective study involving 79 consecutive patients undergoing multiparametric 3T MRI. Each patient was scanned twice in the same session: first with a standard 6-channel surface coil (non-ERC MRI) and then with a combination of a 16-channel surface coil and an inflatable endorectal coil (ERC MRI).
For volume assessment, a radiologist manually contoured the prostate on each axial T2-weighted (T2W) MRI slice. This planimetric method was used to determine the whole prostate (WP) volume in milliliters (cm³). PSA density was then calculated by dividing the patient's serum PSA level by their measured prostate volume.
To evaluate shape changes, key dimensions were measured: the maximum anterior-posterior (AP), left-right (LR), and craniocaudal (CC) dimensions. These measurements were taken from specific T2W MRI slices (axial for AP and LR, coronal for CC) using specialized software. The researchers ensured consistency by using intraprostatic landmarks (like the urethra) to align measurements between the ERC and non-ERC scans. Statistical analysis, including Wilcoxon's signed rank test and paired Student's t-tests, was used to compare the measurements obtained with and without the ERC.
Datasets
The study utilized data from 79 consecutive patients who underwent MRI scans. No new datasets were introduced. The data collected consisted of T2W MRI images acquired with and without an endorectal coil, along with corresponding serum PSA levels.
Key Insights and Ideas
- Shape Deformation vs. Volume Constancy: The most striking finding is that while the ERC significantly deforms the prostate's shape (compressing it anteriorly and expanding it laterally and cranio-caudally), it does not lead to a significant change in the overall measured volume. This suggests the prostate is largely incompressible in the context of the forces applied by the ERC.
- Clinical Reliability of ERC MRI: The lack of significant volume change with ERC use is crucial. It means that PSA density calculations, which are highly dependent on accurate volume measurements, remain reliable even when using ERC-enhanced MRI. This is important for clinical decision-making regarding active surveillance and treatment.
- Improved Image Quality: Although not the primary focus of the volume/shape analysis, the paper implicitly acknowledges the benefit of ERC in improving SNR, which can lead to better delineation of prostate margins and potentially more accurate measurements.
Key Results
- Whole Prostate Volume: No statistically significant change in whole prostate volume was observed between non-ERC (57.5 ± 28.4 mL) and ERC (57.9 ± 29.2 mL) MRI (P = 0.270). The percentage difference was a mere 0.6 ± 5.7%.
- PSA Density: Similarly, PSA density showed no significant difference (P = 0.768), with values of 0.245 ± 0.563 ng/mL/cm³ for non-ERC and 0.246 ± 0.583 ng/mL/cm³ for ERC.
- Shape Changes:
- AP Dimension: Significantly decreased by -8.6 ± 7.8% (P < 0.001).
- LR Dimension: Significantly increased by 4.5 ± 5.8% (P < 0.001).
- CC Dimension: Significantly increased by 8.8 ± 6.9% (P < 0.001).
- Clinical Thresholds: Only 2 out of 79 patients (2.5%) crossed the 0.15 ng/mL/cm³ PSA density threshold for active surveillance when using ERC, indicating minimal impact on clinical stratification.
Limitations and Future Work
- In-plane Resolution: The study acknowledges a limitation due to different in-plane image resolutions between non-ERC and ERC MRI. While the ERC's higher SNR can enable better delineation, this resolution difference could theoretically influence measurements.
- Interobserver Variability: While efforts were made to ensure consistent contouring, the inherent potential for interobserver variability in manual segmentation is a general limitation of planimetric methods.
- Future Work: The authors suggest that these findings can improve registration algorithms for integrating CT and MRI data for radiation therapy planning, potentially enhancing treatment effectiveness. Further research could explore the impact of ERCs on zonal prostate volume measurements and their implications for more localized cancer detection.
Summary updated